CAS No. |
79517-01-4 |
英文名称 |
13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate |
别名 |
SANDOSTATIN;SMS-201-995;[r-(r*,r*)]-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;OCTREOTIDE;OCTREOTIDE (SMS 201-995), ACETATE;cyclic(2-7)-disulfide,(r-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl);Octreotide
(D-Phe5,Cys6·11,D-Trp8,L-Threoninol12)-SoMatostatin-14 (5-12), SMS-201-995;D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxyMethyl)propyl]- |
标准英文名 |
13-((1H-indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide diacetate |
分子式 |
C53H74N10O14S2 |
分子量 |
1139.36
|
精确分子量 |
1138.48
|
SMILES |
CC(=O)O.CC(=O)O.CC(O)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(NC(=O)C(N)CC2=CC=CC=C2)CSSCC(C(=O)N[C@H](CO)[C@@H](C)O)NC1=O |
标准SMILES |
CC(O)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2C=CC=CC=2)NC(=O)C(CSSCC(NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)C(N)CC1C=CC=CC=1.CC(O)=O.CC(O)=O |
用途 |
Octreotide is primarily used for the treatment of esophageal variceal bleeding due to portal hypertension, acromegaly, gastrointestinal bleeding (including bleeding from liver cirrhosis, esophageal varices, peptic ulcers, and stress ulcers), pancreatic diseases (such as severe acute pancreatitis, pancreatic fistula after pancreatic trauma or surgery), and prevention of complications following pancreatic surgery. It is also used for gastrointestinal fistulas, gastroenteropancreatic endocrine tumors (including VIPomas, gastrinomas, glucagonomas, ectopic ACTH syndrome, and carcinoid syndrome), acromegaly, Graves' ophthalmopathy, persistent and refractory diarrhea after total colectomy, and AIDS-related diarrhea. Additionally, intrathecal administration of octreotide can be used for the management of cancer-related pain. |
InChIKey |
QWFYIFWTVZFPRY-AARKYNAGSA-N |